BRD4 and ovarian carcinoma: Following the discovery that Ovcar4 cells overexpressing BRD4-S isoform showed an extensive DNA damage, we inquired about their response to DNA-damaging agents, such as cisplatin, which is used as a standard care treatment for ovarian carcinoma patients.